Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Pure sensory Guillain-Barré syndrome: A case report and review of the literature.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
LSN MS guidelines for the management of multiple sclerosis.
Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.
Activated microglia enhance neurogenesis via trypsinogen secretion.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Drug therapy for multiple sclerosis.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.

Pages